chr3-184135283-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The ENST00000491144.5(EIF2B5):n.246C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0236 in 1,483,838 control chromosomes in the GnomAD database, including 499 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.018 ( 42 hom., cov: 33)
Exomes 𝑓: 0.024 ( 457 hom. )
Consequence
EIF2B5
ENST00000491144.5 non_coding_transcript_exon
ENST00000491144.5 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.225
Genes affected
EIF2B5 (HGNC:3261): (eukaryotic translation initiation factor 2B subunit epsilon) This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0183 (2781/152364) while in subpopulation NFE AF= 0.0263 (1791/68050). AF 95% confidence interval is 0.0253. There are 42 homozygotes in gnomad4. There are 1283 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 42 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF2B5-DT | NR_183718.1 | upstream_gene_variant | ||||||
EIF2B5-DT | NR_183719.1 | upstream_gene_variant | ||||||
EIF2B5-DT | NR_183720.1 | upstream_gene_variant | ||||||
EIF2B5-DT | NR_183721.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF2B5 | ENST00000491144.5 | n.246C>G | non_coding_transcript_exon_variant | 1/15 | 2 | |||||
EIF2B5-DT | ENST00000608135.1 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0183 AC: 2782AN: 152246Hom.: 42 Cov.: 33
GnomAD3 genomes
AF:
AC:
2782
AN:
152246
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0243 AC: 32297AN: 1331474Hom.: 457 Cov.: 22 AF XY: 0.0244 AC XY: 16084AN XY: 659334
GnomAD4 exome
AF:
AC:
32297
AN:
1331474
Hom.:
Cov.:
22
AF XY:
AC XY:
16084
AN XY:
659334
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0183 AC: 2781AN: 152364Hom.: 42 Cov.: 33 AF XY: 0.0172 AC XY: 1283AN XY: 74502
GnomAD4 genome
AF:
AC:
2781
AN:
152364
Hom.:
Cov.:
33
AF XY:
AC XY:
1283
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
23
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Vanishing white matter disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at